Absolute oral bioavailability of milvexian spray‐dried dispersion formulation under fasted and fed conditions in healthy adult participants: An intravenous microtracer approach
Abstract Milvexian is an oral, small‐molecule factor XIa inhibitor being developed to prevent thromboembolic events. This study assessed the absolute bioavailability (F) of milvexian following single doses of milvexian spray‐dried dispersion (SDD) formulation under fed and fasted conditions, and mil...
Saved in:
Main Authors: | Praneeth Jarugula (Author), Sharif Soleman (Author), Hyunmoon Back (Author), Lisa J. Christopher (Author), Dara Hawthorne (Author), Ronald Aronson (Author), Anh Bui (Author), Angela Mirzac (Author), Antoinette Ajavon‐Hartmann (Author), Vidya Perera (Author), Bindu Murthy (Author), Samira Merali (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
First‐in‐human study of milvexian, an oral, direct, small molecule factor XIa inhibitor
by: Vidya Perera, et al.
Published: (2022) -
The application of Phase 0 and microtracer approaches in early clinical development: past, present, and future
by: A. F. Roffel, et al.
Published: (2024) -
CMC development of [14C]-labeled sotorasib for the conduct of microtracer human ADME study
by: Sonika Sharma, et al.
Published: (2023) -
An Investigation of the Metabolism and Excretion of KD101 and Its Interindividual Differences: A Microtracing Mass Balance Study in Humans
by: Anhye Kim, et al.
Published: (2021) -
Investigation of the human metabolism and disposition of the prolyl hydrolase inhibitor daprodustat using IV microtracer with Entero‐Test bile string
by: Guoying Tai, et al.
Published: (2023)